Entrada Therapeutics, Inc. (TRDA)
NGM · Common · CUSIP 29384C108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TRDA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
29384C108
Market Cap
Mid Cap
IPO
10/29/2021 · $20.00/share
Business: Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles (EEV™), to engage intracellular targets that have long been considered inaccessible and undruggable.

Company Contact

CEO
Dipal Doshi
CFO
Jason J. Lisowski
Headquarters
6 Tide Street, Boston, MA 02210
Phone
857-520-9158
Investor Relations
Karla MacDonald · kmacdonald@entradatherapeutics.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »